Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Imatinib and Docetaxel in Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE3
Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2